Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Ronald Petersen(Mayo Clinic), Ronald G. Thomas(University of California, San Diego), Michael Grundman, David Bennett(Rush University Medical Center), Rachelle S. Doody(Baylor College of Medicine), Steven H. Ferris(New York University), Douglas Galasko(University of California, San Diego), Shelia Jin(University of California, San Diego), Jeffrey Kaye(Oregon Health & Science University), Allan I. Levey(Emory University), Eric Pfeiffer(University of South Florida), Mary Sano, Christopher H. van Dyck(Yale University), Leon J. Thal(University of California, San Diego)
Cited by 1,857Open Access
Abstract
The new england journal of medicine * CI denotes confidence interval. P values were not adjusted for multiple comparisons. In the donepezil group, when corrected for multiple comparisons, the P value at 24 months for all subjects became nonsignificant (P=0.052), and the P value at 36 months for APOE e 4 carriers also became nonsignificant (P=0.078).
Related Papers
No related papers found
Powered by citation graph analysis